EGEN AUTO Targets Global Market with ‘K-Self Car Maintenance’
ANSAN, South Korea–(BUSINESS WIRE)–#AI—EGEN AUTO, a company that has emerged as a pioneer in automotive aftermarket innovation, is planning to... Read more.
Wolters Kluwer Launches Capego Practice Management – A Cloud Solution for Modern Tax and Accounting Firms
This cloud-based software system brings together everything tax and accounting firms need into one powerful, connected platform that’s fully integrated with the... Read more.
Wolters Kluwer Launches Capego Practice Management – A Cloud Solution for Modern Tax and Accounting Firms
This cloud-based software system brings together everything tax and accounting firms need into one powerful, connected platform that’s fully integrated with the... Read more.
k-ID Welcomes Australian Government’s Rigorous Trial of the Latest Online Child Safety Solutions and Agrees the Technological Infrastructure Now Exists for Immediate Action
Independent Australian government trial confirms k-ID’s readiness for deployment under upcoming enforcement deadlines with a top-level grading SINGAPORE–(BUSINESS... Read more.
New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM
− Sustained Benefit of Vutrisiran Across Mortality, Cardiovascular Events, Quality of Life and Cardiac Biomarkers Observed Through Up to 48 Months, Including 12... Read more.
Gold Reserve Provides Update on U.S. Government’s Statement of Interest Supporting Venezuelan Opposition Government in Litigation Regarding Validity of 2020 PDVSA Bonds
PEMBROKE, Bermuda–(BUSINESS WIRE)–Gold Reserve Ltd. (TSX.V: GRZ) (BSX: GRZ.BH) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announces that... Read more.
Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C
Initiation of the development of new oral triple combination tablets, aimed at improving adherence and outcomes in low-density lipoprotein cholesterol (LDL-C) management.... Read more.
Daiichi Sankyo Announces the Development of a Fixed-Triple Combination Lipid-Lowering Tablet to Address Persistent Gaps in the Management of Elevated LDL-C
MUNICH, Germany–(BUSINESS WIRE)–Daiichi Sankyo Europe is pleased to announce the development of a fixed-triple oral combination lipid-lowering tablet... Read more.
Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension
– Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3 – – In the Phase... Read more.
Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial
– Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society of Cardiology Congress 2025 –... Read more.